Watch Out for Severe Hypotension with Flibanserin (Addyi)

October 2015

Expect more symptomatic hypotension in the ED...due to flibanserin (Addyi, ADD-ee), the first drug for hypoactive sexual desire in women.

It's generating a lot of excitement...but be aware of risks.

Flibanserin can cause as much as a 54 mmHg drop in systolic BP or 46 mmHg drop in diastolic when combined with alcohol...leading to syncope in one in 6 patients.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Infectious Diseases Use Steroids to Help Reduce Complications in Severe CAP Patients
Extravasations Select Non-Chemo Extravasation Treatment Based on the Offending Med
Anticoagulants Use a Checklist to Help Patients Safely Take DOACs
Biosimilars Check Insurance Coverage at Discharge for Biologics and Biosimilars
New Drugs Watch Out for Severe Hypotension with Flibanserin (Addyi)
Diabetes Lookout for Severe Joint Pain with Gliptins
Substance Use Disorder Look Out for OTC and Rx Meds That Can Be Abused
HIV & AIDS Double Check for Drug Interactions with HIV Therapy
Oral Health Discourage Prophylactic Antibiotics Before Dental Work in Hip/Knee Replacements
Vaccines Add Meningitis B Vaccine to Your Hospital's Asplenia Vaccine Protocol
Interactions Watch for Hypoglycemia in Patients Taking Repaglinide Plus Clopidogrel
Dosing Don't Cap the Dose of Most Chemo Meds in Obese Patients

Watch Out for Severe Hypotension with Flibanserin (Addyi)

Get unlimited access through an Enterprise license

Table of Contents